Families Fund Rare‑Disease Research

When conventional funders neglect ultra‑rare conditions, families often create nonprofits and crowdfunding campaigns to seed translational research and trials. These family‑led efforts can marshal millions, attract scientists, and set research agendas outside traditional institutional pipelines. — This shift changes who sets biomedical priorities, raises equity and oversight questions, and affects which therapies reach trials and patients first.